| || ||     |
How to Enroll
As of July 18, 2011 we are accepting AIG study subjects at our Casey Eye Institute/OHSU Clinical Center in Portland, Oregon. All other clinical centers are no longer enrolling subjects for this study.
Please contact Janice Van Norman, the AIGS study coordinator at OHSU, at (503) 494-8024 or at email@example.com for more information.
To enroll in the AIG Study, a subject must:
The patient must also fit into one of the following groups:
SUBJECTS WITH NORMAL EYES
The subject has no signs of glaucoma changes in either eye.
EYES AT RISK FOR DEVELOPING GLAUCOMA (GLAUCOMA SUSPECT AND PRE-PERIMETRIC GLAUCOMA)
The eye has a risk factor for developing glaucoma or show early signs of developing glaucoma. The risk factors include increased IOP and a fellow eye being diagnosed with glaucoma. Signs may include changes to the optic nerve and retina. However, these eyes have a normal or borderline visual field test.
EYES WITH GLAUCOMA (PERIMETRIC GLAUCOMA)
The eye definitely has glaucoma, based on both an abnormal optic nerve appearance and abnormal visual field tests.
Patients with normal eyes will be compensated $50 per visit for their participation. Compensation will not be provided for subjects in either the glaucoma group or the at-risk group. Advanced imaging test, other study-specific tests and extra study visit are provided without charge. Visit and treatments that are considered part of routine care will be charged to the patients or their insurance. All participants will receive free parking.
The OHSU Clinical Center is the only center in the active recruitment phase. We are recruiting for all subject categories.
The overall recruitment goal for the AIGS study is a total of 665 patients: 170 for the normal eye group, 175 for the already-diagnosed glaucoma group, and 320 for the at-risk or glaucoma group.
|Copyright 2005 AIG Study. All rights reserved.|